Sec Form 4 Filing - SPIEGELMAN DANIEL K @ BIOMARIN PHARMACEUTICAL INC - 2013-03-18

FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person SPIEGELMAN DANIEL K 2. Issuer Name and Ticker or Trading Symbol BIOMARIN PHARMACEUTICAL INC [ BMRN] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director _____ 10% Owner X __ Officer (give title below) _____ Other (specify below) EVP, Chief Financial Officer (Last) (First) (Middle) 105 DIGITAL DRIVE 3. Date of Earliest Transaction (MM/DD/YY) 03/18/2013 (Street) NOVATO, CA94949 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) __ X __ Form filed by One Reporting Person _____ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock 03/18/2013 03/18/2013 A( 1 ) 7 A $ 61.4829 68,683 D Common Stock 03/18/2013 03/18/2013 A( 1 ) 7 A $ 61.3814 68,690 D Common Stock 03/20/2013 03/20/2013 A( 1 ) 5 A $ 61.988 68,695 D Common Stock 03/20/2013 03/20/2013 A( 1 ) 4 A $ 61.4325 68,699 D Common Stock 06/19/2013 06/19/2013 A( 1 ) 9 A $ 58.5678 68,708 D Common Stock 06/19/2013 06/19/2013 A( 1 ) 9 A $ 58.8478 68,717 D Common Stock 09/10/2013 09/10/2013 A( 1 ) 8 A $ 70.0583 68,725 D Common Stock 09/10/2013 09/10/2013 A( 1 ) 7 A $ 70.3029 68,732 D Common Stock 10/04/2013 10/04/2013 A( 1 ) 5 A $ 74.074 68,737 D Common Stock 10/07/2013 10/07/2013 A( 1 ) 6 A $ 74.8383 68,743 D Common Stock 10/30/2013 10/30/2013 A( 1 ) 4 A $ 66.475 68,747 D Common Stock 10/30/2013 10/30/2013 A( 1 ) 5 A $ 65.75 68,752 D Common Stock 11/20/2013 11/20/2013 A( 1 ) 8 A $ 65.8863 68,760 D Common Stock 03/05/2014 03/05/2014 S( 1 )( 2 ) 12 D $ 82.9258 68,748 D Common Stock 05/02/2014 05/02/2014 S( 1 ) 3 D $ 58.0233 68,745 D Common Stock 05/02/2014 05/02/2014 S( 1 ) 8 D $ 58.78 68,737 D Common Stock 08/06/2014 08/06/2014 A( 1 ) 7 A $ 62.1671 68,744 D Common Stock 08/06/2014 08/06/2014 A( 1 ) 7 A $ 62.1771 68,751 D Common Stock 09/03/2014 09/03/2014 S( 1 )( 2 ) 9 D $ 69.8289 68,742 D Common Stock 09/03/2014 09/03/2014 S( 1 )( 2 ) 9 D $ 69.7011 68,733 D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other SPIEGELMAN DANIEL K 105 DIGITAL DRIVE NOVATO, CA94949 EVP, Chief Financial Officer Signatures /s/ Laura Randall Woodhead, Attorney-in-Fact 02/10/2015 Signature of Reporting Person Date

Explanation of Responses:

( 1 )Inadvertent transaction not directed by the reporting person through a broker-administered investment pool. ( 2 )Some of the transactions executed as reported herein resulted in a short swing profit under Section 16(b) of the Securities Exchange Act of 1934, as amended ("Section 16(b)"). The Reporting Person has made arrangements with the Issuer to disgorge short swing profits realized to the Issuer, and upon settlement, the Reporting Person will have discharged in full any obligation under Section 16(b) with respect to the reported transactions.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.